Charles Lee of The Jackson Laboratory inducted as a fellow of The Korean Academy of Science and Technology

2023-12-14
FARMINGTON, Conn., Dec. 14, 2023 /PRNewswire/ -- The Korean Academy of Science and Technology (KAST), the highest institution of its kind in South Korea, announced Charles Lee, Ph.D., FACMG, as a newly inducted fellow of the Academy. This recognition is given to scientists and engineers who have been active in their field for more than 20 years and made significant contributions during that time.
Lee is the scientific director and professor at The Jackson Laboratory for Genomic Medicine, and is the Robert Alvine Family Endowed Chair. He was awarded the KAST honor in recognition of his extensive global contributions to human genomics research.  Dr. Lee is one of 33 newly appointed fellows to the academy this year. With a total limit of 500 active fellows at KAST, divided across five research areas, he will be one of just 150 current fellows of the Academy's Faculty of Natural Science.
"I am profoundly honored to join so many inspirational scientists and colleagues who are members of the Korean Academy of Science and Technology, and am deeply grateful for this tremendous opportunity," says Lee. "At The Jackson Laboratory, we are ideally poised at the interface between human and mouse genetics, to fully realize precision medicine, and we are fully dedicated to improving human health. Understanding structural genomic variation in human biology, evolution and disease has already uncovered many new targets for treatment and still holds so much more potential to significantly impact human health.  I couldn't be more pleased with the advances we're making."
The academy highlighted several of Lee's accomplishments, including his pioneering discovery of structural mutations in everyone's genomes, linkage of structural mutations to genetic disease as well as his recent success in deciphering the first complete genetic sequences of 43 human
Y chromosomes from lineages from around the world.
At JAX,
the Lee
lab applies state-of-the-art technologies to study structural genomic variation and its contributions to human diseases and vertebrate genome evolution. Dr. Lee is also responsible for the scientific direction and coordination of The Jackson Laboratory (JAX) for Genomic Medicine. He joined JAX in 2013 from Harvard Medical School and Brigham and Women's Hospital. Throughout his career, Dr. Lee has received numerous accolades and awards for his research into the human genome, including an Award from the American Association for Cancer Research (AACR) in 2007 and the 2008 Ho-Am Prize in Medicine. He is also an elected fellow of the American Association for the Advancement of Science (AAAS), a Thompson Reuters Citation Laureate and was previously president of the Human Genome Organization (HUGO) from 2017-2023.
Lee will be inducted at a KAST inception ceremony on January 17, 2024.
SOURCE The Jackson Laboratory
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。